Evommune (EVMN) Other Gross PP&E Adjustments (2024 - 2026)

Evommune (EVMN) has 3 years of Other Gross PP&E Adjustments data on file, last reported at -$4.9 million in Q1 2026.

• Quarterly Other Gross PP&E Adjustments changed N/A year-over-year to -$4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.9 million (changed N/A YoY) and the FY2025 annual result came in at $1.1 million, down 39.84% from the prior year.
• Other Gross PP&E Adjustments fell to -$4.9 million in Q1 2026 per EVMN's latest filing, from $1.1 million in the prior quarter.
• Across five years, Other Gross PP&E Adjustments topped out at $1.8 million in Q4 2024 and bottomed at -$4.9 million in Q1 2026.
• The 3-year median for Other Gross PP&E Adjustments is $462000.0 (2025), against an average of -$540750.0.
• Peak annual rise in Other Gross PP&E Adjustments reached 39.84% in 2025, while the deepest fall reached 39.84% in 2025.
• Tracing EVMN's Other Gross PP&E Adjustments over 3 years: stood at $1.8 million in 2024, then sank by 39.84% to $1.1 million in 2025, then slumped by 551.01% to -$4.9 million in 2026.
• Per Business Quant, the three latest EVMN Other Gross PP&E Adjustments figures stand at -$4.9 million (Q1 2026), $1.1 million (Q4 2025), and -$160000.0 (Q3 2025).

Peer Comparison